Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nesolicaftor (PTI-428) in Cystic Fibrosis Subjects on Tezacaftor/Ivacaftor
NCT03591094Phase 2Completed
- Sponsor
- Proteostasis Therapeutics
- Start
- Aug 2018
- Primary completion
- Feb 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of nesolicaftor in cystic fibrosis (CF), sponsored by Proteostasis Therapeutics. Started Aug 2018; status: completed.
02
Drugs
nesolicaftor
03
Conditions
cystic fibrosis (CF)
Beyond the preview
Go deeper on NCT03591094.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03591094.